Boston Scientific
440 hedge funds and large institutions have $15.7B invested in Boston Scientific in 2014 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 125 increasing their positions, 198 reducing their positions, and 44 closing their positions.
133% more call options, than puts
Call options by funds: $62.2M | Put options by funds: $26.7M
86% more funds holding in top 10
Funds holding in top 10: 7 → 13 (+6)
11% more capital invested
Capital invested by funds: $14.1B → $15.7B (+$1.58B)
0.1% less ownership
Funds ownership: 87.77% → 87.66% (-0.1%)
9% less first-time investments, than exits
New positions opened: 40 | Existing positions closed: 44
2% less funds holding
Funds holding: 450 → 440 (-10)
37% less repeat investments, than reductions
Existing positions increased: 125 | Existing positions reduced: 198
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$237M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$184M |
| 3 |
JP Morgan Chase
New York
|
+$83.9M |
| 4 |
GE
General Electric
Evendale,
Ohio
|
+$81.4M |
| 5 |
CCI
Columbus Circle Investors
|
+$61.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$148M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$107M |
| 3 |
FC
Fairpointe Capital
Chicago,
Illinois
|
-$89M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$65.4M |
| 5 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
-$42.7M |
BSX Hedge Fund Activity: Q1 2014 in Review
440 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q1 2014, worth a combined $15.7B — up 11% from $14.1B a quarter earlier.
Sellers outnumbered buyers: 44 funds closed out of BSX and 40 opened new positions — a net loss of 4 holders — while 198 trimmed existing stakes and 125 added.
The largest buyer was Fidelity Investments, adding an estimated $237M. The largest seller was Goldman Sachs, cutting an estimated $148M.
- 440 institutional investors held Boston Scientific (BSX) as of Q1 2014, down from 450 in Q4 2013.
- Funds reported $15.7B of Boston Scientific stock for Q1 2014, up 11% quarter-over-quarter.
- 40 funds opened new Boston Scientific positions in Q1 2014 and 44 closed out, a net change of -4 holders.
- The largest Boston Scientific buyer in Q1 2014 was Fidelity Investments, an estimated $237M added.
- The largest Boston Scientific seller in Q1 2014 was Goldman Sachs, an estimated $148M sold.
Based on aggregated 13F filings for Q1 2014.